Table 3: Lost productivity and mode of transportation related to SCIT.
|
|
Adults |
Caregivers |
|
Transportation |
||
|
By car (driver) |
24% |
36% |
|
By car (passenger) |
24% |
52% |
|
By taxi/Über |
3% |
1% |
|
By public transportation |
20% |
5% |
|
By bike/motorbike/walking |
18% |
3% |
|
Other ways |
8% |
3% |
|
I don’t know/Can’t remember |
2% |
0% |
|
Missed work due to AIT/accompanying a child to AITa |
||
|
Fully |
25% |
21% |
|
Partly |
34% |
46% |
|
No |
40% |
33% |
|
Received AIT during school hours (children) |
||
|
Fully |
- |
30% |
|
Partly |
- |
45% |
|
No |
- |
25% |
|
Productivity loss, medianb |
||
|
Time missed at work, hours |
3 |
3c |
SCIT: subcutaneous immunotherapy. aFor caregivers: a combination of the adults accompanying the child to the clinic; bProductivity loss for the respondents who fully or partly missed work due to AIT; cTotal missed time at work for the adult(s) accompanying a child to the clinic.